Prime Medicine, Inc.·4

Oct 21, 4:31 PM ET

Chung Wendy 4

4 · Prime Medicine, Inc. · Filed Oct 21, 2022

Insider Transaction Report

Form 4
Period: 2022-10-19
Chung Wendy
Director
Transactions
  • Award

    Stock Option (right to buy)

    2022-10-19+9,0069,006 total
    Exercise: $17.00Exp: 2032-10-19Common Stock (9,006 underlying)
Footnotes (1)
  • [F1]The shares underlying this option shall vest in three equal annual installments beginning on September 13, 2022, subject to the Reporting Person's continued service on each such vesting date.

Documents

1 file
  • 4
    wf-form4_166638426814621.xmlPrimary

    FORM 4